The Journal of Pediatrics
Volume 152, Issue 4 , Pages 521-526.e4, April 2008

Potential Interactions of Drug–Natural Health Products and Natural Health Products–Natural Health Products among Children

  • Ran D. Goldman, MD

      Affiliations

    • Pediatric Research in Emergency Therapeutics (PRETx) Program, Division of Pediatric Emergency Medicine, BC Children’s Hospital, Department of Pediatrics, University of British Columbia, and Child & Family Research Institute (CFRI), Vancouver, British Columbia
    • Corresponding Author InformationReprint requests: Ran D. Goldman, MD, Division of Pediatric Emergency Medicine, BC Children’s Hospital, 4480 Oak Street, Vancouver, BC, V6H 3V4, Canada.
  • ,
  • Alex L. Rogovik, MD, PhD

      Affiliations

    • Division of Pediatric Emergency Medicine, The Hospital for Sick Children, Department of Pediatrics, University of Toronto, Toronto, Ontario
  • ,
  • David Lai, BSc

      Affiliations

    • Division of Pediatric Emergency Medicine, The Hospital for Sick Children, Department of Pediatrics, University of Toronto, Toronto, Ontario
  • ,
  • Sunita Vohra, MD, MSc

      Affiliations

    • Complementary and Alternative Research and Education (CARE) Program, Department of Pediatrics, Stollery Children’s Hospital, Faculty of Medicine and Dentistry, University of Alberta, Edmonton, Alberta, Canada.

Received 24 May 2007; received in revised form 18 July 2007; accepted 12 September 2007. published online 09 November 2007.

Objective

To determine the frequency of concurrent use of conventional medications and natural health products (NHP) and their potential interactions in children arriving at an emergency department.

Study design

A survey of parents and patients 0 to 18 years at a large pediatric ED in Toronto, Ontario, Canada.

Results

A total of 1804 families were interviewed in this study. Concurrent drug-NHP use was documented in 355 (20%) of patients and 269 (15%) of NHP users were receiving more than one NHP simultaneously. Theoretically possible NHP-drug or NHP-NHP interactions in the preceding 3 months were identified in 285 (16%) children. There were 35 different NHP-medication interaction pairs and 41 NHP-NHP interaction pairs. NHP-medication interactions were predominantly pharmacokinetic (modified absorption, 35%); potential NHP-NHP interactions were mostly pharmacodynamic (increased risk of bleeding, 47%).

Conclusions

Medications are used concurrently with NHP in every fifth pediatric patient in the emergency department and many NHP users are receiving more than 1 NHP simultaneously. One quarter of all paired medication-NHP or NHP-NHP could potentially cause interactions. Although we can not confirm that these were true interactions resulting in clinical symptoms, parents and health care providers need to balance the potential benefit of concurrent NHP-medication use with its potential harms.

Abbreviations: CAM, Complementary and alternative medicine, ED, Emergency department, NHP, Natural health products, OTC, Over-the-counter

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 30.00 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 Sponsored by the Hospital for Sick Children Foundation’s Research Grants in Complementary and Alternative Therapies and Child and Youth Health Competition and supported by the Child & Family Research Institute (CFRI), BC Children’s Hospital.

PII: S0022-3476(07)00886-4

doi:10.1016/j.jpeds.2007.09.026

The Journal of Pediatrics
Volume 152, Issue 4 , Pages 521-526.e4, April 2008